Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) - December 20, 2024
iGrantWriters
JANUARY 25, 2022
This FOA is part of a suite of NHLBI Catalyze program to advance projects to the point where they can meet the entry criteria for the NHLBI Catalyze Product Definition or Preclinical FOAs. Â Deadline to Apply December 20, 2024
Let's personalize your content